Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2023-04-25 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
南京证券股份有限公司关于南微医学科技股份有限公司使用部分超募资金永久补充流动资金之核查意见
Regulatory Filings
2023-04-25 Chinese
南微医学科技股份有限公司第三届监事会第十次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Nanwei Medical Technology Co., Ltd. It details the approval of various reports and proposals including the 2022 annual financial report, 2023 financial budget, 2022 annual report and summary, profit distribution plan, internal control evaluation report, social responsibility report, fundraising usage report, and the 2023 first quarter report. The document also states that these reports are published on the Shanghai Stock Exchange website and that the resolutions will be submitted to the 2022 annual shareholders meeting for approval. The document itself is a formal announcement of the Supervisory Board's meeting decisions rather than the reports themselves. The length is 3562 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official regulatory announcement of meeting resolutions and report approvals, not the reports themselves.
2023-04-25 Chinese
中天运会计师事务所（特殊普通合伙）关于南微医学科技股份有限公司2022年内部控制审计报告
Regulatory Filings
2023-04-25 Chinese
南微医学科技股份有限公司关于改聘公司2023年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the change of the company's 2023 annual audit firm. It details the new and former audit firms, reasons for the change, communication with the firms, and approvals from the audit committee, independent directors, and board of directors. It explicitly states that the change will be submitted to the 2022 annual shareholders' meeting for approval. The document does not contain any financial statements or audit reports themselves, but rather is a formal announcement about the appointment of the audit firm for the upcoming audit period. This fits the category of Audit Report / Information (AR) as it relates to audit firm information and audit-related disclosures but is not a full annual report or audit report itself. The document length is under 5,000 characters, but it is not merely announcing the publication of a report; it is announcing a change in audit firm for the annual audit. Therefore, the best classification is AR with high confidence. FY 2023
2023-04-25 Chinese
南微医学科技股份有限公司独立董事关于第三届董事会第十二次会议相关事项的独立意见
Regulatory Filings
2023-04-25 Chinese
南微医学科技股份有限公司关于变更公司注册资本、修订公司章程并办理工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company 南微医学科技股份有限公司 regarding changes to the company's registered capital and amendments to the company's articles of association (章程). It details the approval of these changes by the board and mentions that the changes will be submitted to the annual shareholders' meeting for approval. The document is relatively short (1000 characters) and primarily serves as a formal announcement of corporate governance changes related to capital and articles of association, not a full financial report or detailed management discussion. It does not contain financial statements or detailed financial analysis. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-04-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.